This study is Post Authorization Safety Study (PASS) Phase IV of Booster IndoVac COVID-19Vaccination
This study is Post Authorization Safety Study (PASS) Phase IV, to assess any local and
systemic reaction after immunization with IndoVac using retrospective cohort study trial
design to assess safety profile following IndoVac booster vaccine in healthy populations
aged 18 years and above.
Inclusion Criteria:
1. Clinically healthy subjects aged 18 years and above
2. Subjects have been injected with IndoVac booster.
3. Minimum 6-month interval from primary or booster COVID-19 vaccination.
4. Subjects have been informed properly regarding the study and signed the informed
consent form.
Exclusion Criteria:
1. Subjects concomitantly enrolled or scheduled to be enrolled in another study when
the subjects got IndoVac booster vaccination.
2. Subject's telephone number is invalid or cannot be contacted.
Gambir Public Health Center
Jakarta 1642911, Center Jakarta, Indonesia
Kemayoran Public Health Center
Jakarta 1642911, Center Jakarta, Indonesia
Menteng Public Health Center
Jakarta 1642911, Center Jakarta, Indonesia
Sawah Besar Public Health Center
Jakarta 1642911, Center Jakarta, Indonesia
Tanah Abang Public Health Center
Jakarta 1642911, Center Jakarta, Indonesia
Cakung Public Health Center
Jakarta 1642911, East Jakarta, Indonesia
Cipayung Public Health Center
Jakarta 1642911, East Jakarta, Indonesia
Ciracas Public Health Center
Jakarta 1642911, East Jakarta, Indonesia
Makasar Public Health Center
Jakarta 1642911, East Jakarta, Indonesia
Matraman Public Health Center
Jakarta 1642911, East Jakarta, Indonesia
Pulogadung Public Health Center
Jakarta 1642911, East Jakarta, Indonesia
Cilincing Public Health Center
Jakarta 1642911, North Jakarta, Indonesia
Kelapa Gading Public Health Center
Jakarta 1642911, North Jakarta, Indonesia
Koja Public Health Center
Jakarta 1642911, North Jakarta, Indonesia
Pademangan Public Health Center
Jakarta 1642911, North Jakarta, Indonesia
Cilandak Public Health Center
Jakarta 1642911, South Jakarta, Indonesia
Jagakarsa Public Health Center
Jakarta 1642911, South Jakarta, Indonesia
Kebayoran Baru Public Health Center
Jakarta 1642911, South Jakarta, Indonesia
Mampang Public Health Center
Jakarta 1642911, South Jakarta, Indonesia
Pancoran Public Health Center
Jakarta 1642911, South Jakarta, Indonesia
Pesanggrahan Public Health Center
Jakarta 1642911, South Jakarta, Indonesia
Cengkareng Public Health Center
Jakarta 1642911, West Jakarta, Indonesia
Grogol Petamburan Public Health Center
Jakarta 1642911, West Jakarta, Indonesia
Kalideres Public Health Center
Jakarta 1642911, West Jakarta, Indonesia
Kebon Jeruk Public Health Center
Jakarta 1642911, West Jakarta, Indonesia
Kembangan Public Health Center
Jakarta 1642911, West Jakarta, Indonesia
Palmerah Public Health Center
Jakarta 1642911, West Jakarta, Indonesia
Imunicare Bio Farma
Bandung 1650357, West Java 1642672, Indonesia
Hindra Irawan Satari, Prof., Dr., dr., SpA(K), M. Trop. Paed, Principal Investigator
National Committee of Adverse Events Following Immunization / NC Indonesia